Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 7 recruiting now full pipeline small index

Dyspepsia: full-pipeline trial registry

7 of 12 indexed Dyspepsia trials are currently recruiting.

Corpus placement: #1,429 of 28,707 conditions by registered trial count.

12 US clinical trials · 7 currently recruiting · #1,429 of 28,707 conditions by registered trial count

Dyspepsia: 12 US clinical trials tracked, 7 recruiting.

Dyspepsia is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Mayo Clinic, running 2 of these trials.

Enrollment posture brief

Registry condition dyspepsia

OPEN 7 | RECR 58% | LATE 3 | EARLY 2 | RANK #1429 | SPON 2

Nearest open-share peer: Anterior Cruciate Ligament Reconstruction (58% recruiting · 12 trials)

Dyspepsia (this)58%Acute Myeloid Leukemia in Re41.7%Adenocarcinoma of the Rectum41.7%Adherence, Patient16.7%Accelerated Phase Chronic My0%
Open-enrollment share among volume-matched conditions near Dyspepsia

Dyspepsia lists 7 open slots (58% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Dyspepsia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Dyspepsia is recruiting above its size-band peers.

    7 of 12 indexed trials (58.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Dyspepsia research.

    Mayo Clinic accounts for 2 of 12 trials (16.7%). 10 distinct sponsors appear on at least one study for this condition label.

  3. Most Dyspepsia trials plan to enrol fewer than 100 people.

    Median target enrolment is 64 among the 12 trials that report a genuine target (sentinel values excluded). 9 of those (75%) plan for fewer than 100 participants.

  4. Dyspepsia research is mostly interventional.

    12 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21Phase 32Phase 41

Open and recent trials

12 total, page 1 of 1

RECRUITING Phase 3 200 participants

Domperidone in Treating Patients With Gastrointestinal Disorders

M.D. Anderson Cancer Center

NCT01696734

RECRUITING NA 100 participants

Visible Abdominal Distension

Hospital Universitari Vall d'Hebron Research Institute

NCT06369753

RECRUITING NA 100 participants

High Resolution Gastric Mapping and Gastroduodenal Manometry

Mayo Clinic

NCT06941545

RECRUITING Phase 4 80 participants

Famotidine and Antacids for Treatment of Dyspepsia

Stony Brook University

NCT06241183

RECRUITING NA 65 participants

Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

Massachusetts General Hospital

NCT03603730

RECRUITING NA 64 participants

Zypan Functional Dyspepsia

National University of Natural Medicine

NCT06320379

RECRUITING NA 50 participants

Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia

Massachusetts General Hospital

NCT05587127

ACTIVE NOT RECRUITING NA 17 participants

Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility

University of California, Los Angeles

NCT05004012

COMPLETED Phase 3 60 participants

The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.

Novartis

NCT00171470

COMPLETED Phase 1 50 participants

Use of MRI for Assessing Stomach Relaxation in Response to a Meal

Mayo Clinic

NCT00275743

COMPLETED Phase 2 45 participants

Study of Motilitone to Treat Functional Dyspepsia

Dong-A ST Co.

NCT02365701

COMPLETED NA 14 participants

Melatonin in Pediatric FD Population

Children's Mercy Hospital Kansas City

NCT04684199

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 2
Phase 4 1

Named interventions

Most-linked intervention names on Dyspepsia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Motilitone 30mg Drug
1 trials
Tegaserod Drug
1 trials
Magnetically Controlled Capsule Endoscopy Device
1 trials
Oral Maalox/ Mylanta Drug
1 trials
Intravenous Famotidine Drug
1 trials
Gastroduodenal Manometry Device
1 trials
tVNS Device
1 trials
Alimetry Device
1 trials

US sites by state

Facility locations filed on Dyspepsia trials. A trial with sites in several states counts in each.

Minnesota 3 trials
Massachusetts 2 trials
California 2 trials
Texas 1 trials
Oregon 1 trials
New York 1 trials
New Jersey 1 trials
Missouri 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Dyspepsia page

12 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 7 Dyspepsia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Mayo Clinic sponsors the most Dyspepsia trials on record, review their full trial history before evaluating a specific study. See Mayo Clinic's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dyspepsia condition card totals 12 registered trials; most-linked intervention Motilitone 30mg; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.